Task: Answer the multiple-choice question.
Query: Which drug has a 59.832% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) O=C(CSc1nc2c(sc3ccccc32)c(=O)n1CCCN1CCOCC1)NC1CCCC1
(b) CC(Oc1ccc2c3c(c(=O)oc2c1)CCCC3)C(=O)NCCN1CCOCC1
Answer: b. CC(Oc1ccc2c3c(c(=O)oc2c1)CCCC3)C(=O)NCCN1CCOCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(Oc1ccc2c3c(c(=O)oc2c1)CCCC3)C(=O)NCCN1CCOCC1
CC(Oc1ccc2c3c(c(=O)oc2c1)CCCC3)C(=O)NCCN1CCOCC1
N-(2-morpholin-4-ylethyl)-2-[(6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-3-yl)oxy]propanamide